Zobrazeno 1 - 5
of 5
pro vyhledávání: '"M. V. Pogrebna"'
Autor:
S. O. Cherenko, N. A. Lytvynenko, O. A. Reva, O. V. Khmel, R. A. Veremeenenko, M. V. Pogrebna, Yu. A. Senko
Publikováno v:
Infusion & Chemotherapy, Iss 1, Pp 19-24 (2018)
PURPOSE. To study the efficacy and tolerability of the port catheter for continuous intravenous infusion in patients with MDR-TB and XDR-TB. MATERIALS AND METHODS. In a controlled study examined the effectiveness of the port catheter during an int
Externí odkaz:
https://doaj.org/article/5ed6acd18ae94b3b84b707b6d9f3bb41
Autor:
M. V. Pogrebna, O.R. Penenko, R.L. Liubevych, N.V. Grankina, Yu.I. Feschenko, Nataliia Lytvynenko, L.V. Shcherbakova, A.S. Lapheta
Publikováno v:
Tuberculosis, Lung Diseases, HIV Infection. :5-14
Objеctive — to learn the effectiveness of various shortened standard or modified treatment regimens for patients with multidrugresistant tuberculosis. Materials and methods. A prospective observational study was carried out to study different sh
Autor:
N.I. Grabchenko N.I. Grabchenko, O.R. Panasyukova, T. V. Tlustova, Yu. O. Matvienko, M. V. Pogrebna, O. M. Rekalova, A.V. Taranenko, S.G. Yasir, S. P. Korotchenko, V. M. Zhadan
Publikováno v:
Asthma and allergy. 2021:27-33
Various types of adverse reactions to medications often occur during the treatment of diseases that require the simultaneous administration of several drugs. Methods. To study the effect of the natural hepatoprotector Hepatomunil on immunological and
Autor:
O. V. Khmel, O. A. Reva, M. V. Pogrebna, Yu. A. Senko, Svitlana Cherenko, Nataliia Lytvynenko, R. A. Veremeenenko
Publikováno v:
Infusion & Chemotherapy. :19-24
PURPOSE. To study the efficacy and tolerability of the port catheter for continuous intravenous infusion in patients with MDR-TB and XDR-TB. MATERIALS AND METHODS. In a controlled study examined the effectiveness of the port catheter during an intens
Autor:
Olga Denisiuk, Y. Senko, Rony Zachariah, A.І. Barbova, Andrew Ramsay, Svitlana Cherenko, Marcel Manzi, Y. Feschenko, Nataliia Lytvynenko, M. V. Pogrebna
Publikováno v:
Public health action. 4(Suppl 2)
With a population of 45 million, Ukraine is Europe's second largest country. Tuberculosis (TB) is a major public health problem, and multidrug-resistant TB (MDR-TB) is common. Rates of MDR-TB, defined as Mycobacterium tuberculosis strains resistant t